Contraceptive treatments: A review of current hormone options and newer agents for women; Focus on dabigatran; Agents in late-stage development for the treatment of cystic fibrosis.
Medicare’s Drug Price Negotiations Could Impact Physician Reimbursement
September 19th 2024When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those whose services are covered by commercial insurance, could see lowered reimbursement.
Read More